By Jay Forte, Contributing Reporter
RIO DE JANEIRO, BRAZIL - According to a report by GlobalData, the Brazilian pharmaceutical market is set to grow from US$25.3 billion in 2016 to US$29.9 billion in 2021, representing a compound annual growth rate of 3.5 percent. This is welcome news in the midst of Brazil’s worst economic recession on record.
GlobalData latest report states that Brazil is one of the most attractive and promising pharmaceutical markets in the world, with all major global pharmaceutical companies operating in the country.
Changing demographics are a key driver of the Brazilian . . .